Sixth Day Consecutive Fall & Bloodbath in Indian Stock Market

Indian equity benchmarks, Sensex and Nifty, concluded the week with their most significant weekly decline in six months, marking the sixth consecutive session of losses and hitting three-week lows. The Sensex closed at 80,426.46, a fall of 733.22 points (0.9%), while the Nifty ended at 24,654.70, down by 236.15 points (0.95%). The market sentiment was overwhelmingly negative, with broad-based selling impacting most sectors. Mid and small-cap indices mirrored the trend, each declining by approximately 2%. The India VIX, a measure of market volatility, surged by 7.7%, indicating heightened uncertainty among investors. Key Drivers of the Market Decline Several international and domestic factors contributed to this week's bearish sentiment: #US Tariffs on Pharmaceuticals: A primary catalyst for the downturn was the announcement by US President Donald Trump of a 100% tariff on branded and patented drugs. This move directly impacted the Indian pharmaceutical sector, which exports a significant volume to the US. The Nifty Pharma index plummeted by 2.1%, with industry leaders like Sun Pharma, Dr. Reddy's Laboratories, and Cipla experiencing substantial losses.

#Weakness in the IT Sector: The Information Technology sector faced headwinds following Accenture's latest quarterly results, which suggested a "patchy" recovery in demand. This led to a 2.4% drop in the Nifty IT index, as concerns grow about the future revenue growth for Indian IT firms. Compounding the issue are rising costs and uncertainty associated with US H-1B visa regulations. #Negative Global Cues: The sell-off was exacerbated by weak global markets. Stronger-than-anticipated US economic data has tempered expectations for aggressive interest rate cuts by the Federal Reserve, leading to a downturn on Wall Street and in Asian markets. This global risk-off sentiment has spilled over into the domestic market, further dampening investor confidence.